Seeking Alpha

BCLI
  BrainStorm Cell Therapeutics Inc. - OTCQB

8/22/2014, 8:58 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
BCLI vs. ETF Alternatives
Company Description
BrainStorm Cell Therapeutics Inc. is a clinical-stage biotechnological company developing innovative, adult stem cell therapeutic products, derived from autologous bone marrow cells, for the treatment of highly debilitating neurodegenerative disorders. The company's current primary targets are... More
Sector: Healthcare
Industry: Biotechnology
Country: United States